Schornagel JH - Search Results

1

Gene amplification and altered enzymes as mechanisms for the development of drug resistance.

Bertino JR, Carman MD, Weiner HL, Cashmore A, Moroson BA, Srimatkandada S, Schornagel JH, Medina WD, Dube SK. Bertino JR, et al. Among authors: schornagel jh. Cancer Treat Rep. 1983 Oct;67(10):901-4. Cancer Treat Rep. 1983. PMID: 6354438 Review.

2

Resistance to methotrexate due to gene amplification in a patient with acute leukemia.

Carman MD, Schornagel JH, Rivest RS, Srimatkandada S, Portlock CS, Duffy T, Bertino JR. Carman MD, et al. Among authors: schornagel jh. J Clin Oncol. 1984 Jan;2(1):16-20. doi: 10.1200/JCO.1984.2.1.16. J Clin Oncol. 1984. PMID: 6583326

3

Synthesis and evaluation of 2,4-diaminoquinazoline antifolates with activity against methotrexate-resistant human tumor cells.

Schornagel JH, Chang PK, Sciarini LJ, Moroson BA, Mini E, Cashmore AR, Bertino JR. Schornagel JH, et al. Biochem Pharmacol. 1984 Oct 15;33(20):3251-5. doi: 10.1016/0006-2952(84)90086-8. Biochem Pharmacol. 1984. PMID: 6487372

4

Occurrence and significance of D-methotrexate as a contaminant of commercial methotrexate.

Cramer SM, Schornagel JH, Kalghatgi KK, Bertino JR, Horváth C. Cramer SM, et al. Among authors: schornagel jh. Cancer Res. 1984 May;44(5):1843-6. Cancer Res. 1984. PMID: 6713386

5

In vitro activity of novel antifolates against human squamous carcinoma cell lines of the head and neck with inherent resistance to methotrexate.

van der Laan BF, Jansen G, Kathmann GA, Westerhof GR, Schornagel JH, Hordijk GJ. van der Laan BF, et al. Among authors: schornagel jh. Int J Cancer. 1992 Jul 30;51(6):909-14. doi: 10.1002/ijc.2910510613. Int J Cancer. 1992. PMID: 1639538

6

Mechanisms of acquired resistance to methotrexate in a human squamous carcinoma cell line of the head and neck, exposed to different treatment schedules.

van der Laan BF, Jansen G, Kathmann I, Schornagel JH, Hordijk GJ. van der Laan BF, et al. Among authors: schornagel jh. Eur J Cancer. 1991;27(10):1274-8. doi: 10.1016/0277-5379(91)90096-v. Eur J Cancer. 1991. PMID: 1835598

7

Methotrexate with thymidine protection or rescue in advanced head and neck cancer: a phase II study.

Schornagel JH, Leyva A, Pinedo HM. Schornagel JH, et al. Cancer Treat Rep. 1984 Mar;68(3):543-5. Cancer Treat Rep. 1984. PMID: 6704983 No abstract available.

8

The clinical pharmacology of methotrexate.

Schornagel JH, McVie JG. Schornagel JH, et al. Cancer Treat Rev. 1983 Mar;10(1):53-75. doi: 10.1016/s0305-7372(83)80032-2. Cancer Treat Rev. 1983. PMID: 6342775 Review. No abstract available.

9

Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro.

Oldenburg J, Begg AC, van Vugt MJ, Ruevekamp M, Schornagel JH, Pinedo HM, Los G. Oldenburg J, et al. Among authors: schornagel jh. Cancer Res. 1994 Jan 15;54(2):487-93. Cancer Res. 1994. PMID: 8275486

10

Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.

Jansen G, Westerhof GR, Kathmann I, Rademaker BC, Rijksen G, Schornagel JH. Jansen G, et al. Among authors: schornagel jh. Cancer Res. 1989 May 1;49(9):2455-9. Cancer Res. 1989. PMID: 2706633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters